Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Mark Bernard Leick, M.D.

Concepts (127)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Immunotherapy, Adoptive25202414542.640 Why?
Receptors, Antigen, T-Cell7202425320.950 Why?
Hematologic Neoplasms5202418900.940 Why?
Graft vs Host Disease3202230240.890 Why?
Pulmonary Alveolar Proteinosis12022400.800 Why?
Hematopoietic Stem Cell Transplantation5202456490.680 Why?
Hematologic Diseases220234960.680 Why?
Communication Barriers120204130.560 Why?
Professional-Family Relations120204950.530 Why?
Leukemia, Myeloid, Acute3202235990.510 Why?
Lymphoma, B-Cell120209350.450 Why?
fms-Like Tyrosine Kinase 3120174950.440 Why?
T-Lymphocytes182024101710.440 Why?
Neurotoxicity Syndromes220233000.310 Why?
Lymphohistiocytosis, Hemophagocytic220232640.290 Why?
Physician-Patient Relations1202032420.280 Why?
Glioblastoma4202434800.260 Why?
Communication1202038460.260 Why?
Molecular Targeted Therapy1201727960.260 Why?
Interleukin-7120231420.220 Why?
Transplantation Conditioning2202015880.210 Why?
B-Cell Maturation Antigen120241480.210 Why?
GPI-Linked Proteins120244680.210 Why?
Central Nervous System Neoplasms220229160.200 Why?
Lymphoma2202218960.190 Why?
Xenograft Model Antitumor Assays3202435740.180 Why?
Protein Kinase Inhibitors1201756290.180 Why?
Endopeptidases120247720.180 Why?
Interleukin 1 Receptor Antagonist Protein120222980.180 Why?
Hospital Departments120201340.170 Why?
Translating120201430.160 Why?
Antineoplastic Agents22023135910.160 Why?
Pancytopenia120191010.160 Why?
Humans3720247583810.150 Why?
Cyclophosphamide2202322180.150 Why?
Proto-Oncogene Proteins c-bcl-21202414040.150 Why?
Transduction, Genetic120208960.150 Why?
Lentivirus120205030.150 Why?
Lymphoma, T-Cell, Cutaneous120192090.140 Why?
Neoplasms32023220300.140 Why?
Telephone120206250.140 Why?
Antigen-Presenting Cells120209640.140 Why?
Antibodies, Bispecific120191910.140 Why?
Tandem Repeat Sequences120171800.130 Why?
Multiple Myeloma2202451290.130 Why?
Antigens, Neoplasm2202419970.130 Why?
Sulfonamides1202419730.120 Why?
Ubiquitin-Protein Ligases1202318880.110 Why?
Lymphoma, Non-Hodgkin1202113730.110 Why?
Gene Expression Regulation, Leukemic120176460.110 Why?
Drug Approval120208090.110 Why?
Autoantibodies1202221180.110 Why?
Flow Cytometry1202458640.110 Why?
Biological Products120229060.110 Why?
Lymphoma, Large B-Cell, Diffuse1202214020.100 Why?
United States Food and Drug Administration1202016600.100 Why?
Bone Marrow Transplantation1201926930.100 Why?
Hodgkin Disease1201913770.090 Why?
Organoplatinum Compounds120124050.090 Why?
Tumor Microenvironment1202438400.090 Why?
Antigens, CD19220224240.080 Why?
Apoptosis1202494680.080 Why?
Intensive Care Units1202037320.070 Why?
Cell Line, Tumor42024168860.070 Why?
Pancreatic Neoplasms1202453490.070 Why?
Skin1201944640.060 Why?
Antibodies, Monoclonal1202391600.060 Why?
Neoplasm Staging12020111520.060 Why?
Combined Modality Therapy1201785300.060 Why?
Antigens, CD712024300.060 Why?
Antineoplastic Combined Chemotherapy Protocols22017117090.060 Why?
Disease Progression12020134680.060 Why?
Cytokines3202373380.050 Why?
bcl-X Protein120244110.050 Why?
Drug Resistance, Neoplasm1201752480.050 Why?
France120234990.050 Why?
Clinical Trials as Topic1201779850.050 Why?
Antibodies, Viral2202231420.050 Why?
Transgenes1202410070.050 Why?
Macrophage Activation120225520.040 Why?
Ubiquitination1202310070.040 Why?
Serine Endopeptidases1202410200.040 Why?
Mice52024811070.040 Why?
Codon, Nonsense120192810.040 Why?
Brain Neoplasms1201989810.040 Why?
Adult620242199160.040 Why?
Liver Neoplasms1201243130.030 Why?
Cell Death1202216670.030 Why?
United States22023721400.030 Why?
Transforming Growth Factor beta1202319570.030 Why?
Leukocytes, Mononuclear1202218260.030 Why?
Neoplasm Recurrence, Local2202492730.030 Why?
Fatal Outcome1201918290.030 Why?
Exanthema120195040.030 Why?
Child22023798130.030 Why?
Treatment Outcome22019643790.030 Why?
Neoplasms, Experimental1201912280.030 Why?
Signal Transduction12017233410.030 Why?
Antigens, CD1202439970.030 Why?
Retrospective Studies22019801700.030 Why?
Animals520241677770.030 Why?
Interferon-gamma1202231560.030 Why?
Carcinoma, Pancreatic Ductal1202417240.030 Why?
Mutation12017299150.030 Why?
Infusions, Intra-Arterial120122210.030 Why?
Recurrence1202484260.020 Why?
Fever1201916170.020 Why?
Proto-Oncogene Proteins1202444850.020 Why?
Peptide Fragments1202450980.020 Why?
Hepatic Artery120122300.020 Why?
Aged520241682170.020 Why?
CD8-Positive T-Lymphocytes1202445490.020 Why?
Vaccination1202233560.020 Why?
Bone Marrow1201929090.020 Why?
Middle Aged520242195600.020 Why?
Biopsy1201967680.020 Why?
Membrane Proteins1202478430.020 Why?
Adenocarcinoma1202463130.020 Why?
Cognition1202369550.020 Why?
Incidence12023212730.020 Why?
Male520243587420.020 Why?
Diagnosis, Differential12019129510.010 Why?
Cell Differentiation12019114710.010 Why?
Female420243903160.010 Why?
Young Adult12019588080.010 Why?
Adolescent12019878880.010 Why?
Aged, 80 and over12012586810.000 Why?
Leick's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (127)
Explore
_
Co-Authors (73)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2024 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.